HANMI PHARM. Sustainability Profile
HANMI PHARM, officially known as Hanmi Pharmaceutical Co., Ltd., is a leading player in the global pharmaceutical industry, headquartered in KP. Established in 1973, the company has made significant strides in research and development, particularly in the fields of oncology, diabetes, and autoimmune diseases. With a strong presence in both domestic and international markets, HANMI PHARM is renowned for its innovative drug formulations and advanced biopharmaceuticals. Their core products, including unique oral medications and biologics, set them apart through their efficacy and safety profiles. Recognised for its commitment to quality and innovation, HANMI PHARM has achieved notable milestones, including strategic partnerships and successful product launches that enhance its market position. As a forward-thinking organisation, it continues to contribute to the advancement of healthcare solutions worldwide.
DitchCarbon Score
How does HANMI PHARM.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HANMI PHARM.'s score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HANMI PHARM.'s reported carbon emissions
In 2023, HANMI PHARM. reported total carbon emissions of approximately 143.8 million kg CO2e. This figure includes emissions from all three scopes: Scope 1 emissions totalled about 11.5 million kg CO2e, Scope 2 emissions were approximately 49.7 million kg CO2e, and Scope 3 emissions reached about 82.6 million kg CO2e. The company has demonstrated a commitment to transparency in its emissions reporting, with data disclosed across all relevant scopes. However, there are currently no specific reduction targets or initiatives outlined in their climate commitments. Comparatively, in 2022, HANMI PHARM. reported total emissions of approximately 60.1 million kg CO2e, indicating a significant increase in emissions in 2023. The emissions from Scope 1 and Scope 2 combined were about 61.2 million kg CO2e in 2022, highlighting a shift in their emissions profile. As of now, HANMI PHARM. has not cascaded any emissions data from a parent or related organization, and all reported figures are derived directly from their own disclosures. The company continues to engage in industry-standard practices for emissions reporting, aligning with global climate accountability standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 13,523,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 58,287,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 00,000,000 |
How Carbon Intensive is HANMI PHARM.'s Industry?
How Carbon Intensive is HANMI PHARM.'s Location?
HANMI PHARM.'s Scope 3 Categories Breakdown
Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 57% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 56% of Scope 3 emissions.
Top Scope 3 Categories
HANMI PHARM.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HANMI PHARM. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
